Bioventus Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.21 | — | — | Miss |
| Q12026 FY2026 | $0.09 | $0.15 | +66.7% | Beat |
| 2026-03-10 | $0.22 | — | — | Miss |
Back to BVS overview · BVS holders · BVS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.